Purchase Order 75N98026P01054

<p>The NIH Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,005.00 on September 7, 2018, with completion targeted for September 28, 2018. Performance takes place in Bethesda, Maryland. The order procures next-generation genomic sequencing instruments, consumables, or reagents on a firm fixed-price basis. The originating pre-solicitation was posted July 27, 2018, with bids due August 10, 2018.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $14,325.00 on July 22, 2020, for scientific supplies. Place of performance is Cambridge, Massachusetts. The order has a firm fixed price and an ultimate completion date of August 21, 2020. No set-aside was used.</p>

<p>The NIH Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. valued at $7,310 on September 21, 2017, with completion targeted for October 30, 2017. Performance is located in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not specify the equipment, consumables, or reagents procured under this individual order.</p>

<p>The NIH Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $12,086.00 on May 12, 2020, for a bulk order of 12 flow cells (R9.4), ligation sequencing kits, and control expansion. Performance of the order occurred in Cambridge, Massachusetts, with an ultimate completion date of July 13, 2020. The order was priced on a firm fixed-price basis with no small business set-aside.</p>

<p>The National Institute on Aging awarded a purchase order to Oxford Nanopore Technologies Inc. for $150,000 on October 28, 2024, for a license and warranty covering a PromethION 48 sequencing instrument (serial number P48_051). Performance occurs at Bethesda, Maryland, with an ultimate completion date of October 27, 2025. The order is firm fixed price with no set-aside designation.</p>

The National Institute on Aging awarded a purchase order to Oxford Nanopore Technologies Inc. for $120,000.00 on May 28, 2023, for software license and device warranty services for a PromethION long-read sequencer (serial no. P48-53). Place of performance is Bethesda, Maryland. The order carries firm fixed price terms with no small business set-aside. Performance concludes May 27, 2027. The requirement originated from a pre-solicitation opportunity posted February 23, 2023, with a closing date...

The National Institutes of Health, Office of Acquisitions, awarded a purchase order to Oxford Nanopore Technologies Inc. on June 10, 2026, for sequencing kits and consumables, with a ceiling value of $252,560.00 and a period of performance extending to October 10, 2026. The procurement, issued under FAR 12.603 as a non-competitive, brand-name acquisition, covers 72 units of PromethION Flow Cells Packs DNA (catalog number FLO-PRO114M) and 48 units of cDNA-PCR Sequencing Kit V14 (catalog number...

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,065.00 on September 7, 2017, for an Oxford Nanopore Starter Pack—a device providing ultra-long read DNA and RNA sequencing using nanopores. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and was scheduled for completion by October 20, 2017.</p>

The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $165,000 on April 18, 2019, with a completion date of July 31, 2019. No set-aside applied. Place of performance is Cambridge, Massachusetts. The order procures next-generation sequencing instruments, consumables, and reagents—specifically PromethION 24 platform equipment and compatible flow cell packs and library preparation reagents for genomic sequencing research. The solicitation was...

This firm fixed-price purchase order is valued at $30,000 and was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Oxford Nanopore Technologies Inc. The order is for a software license and device warranty to support the Nanopore Promethion Long Read Sequencer serial number P48_051 located at the NIH in Bethesda, Maryland. The sequencing platform will be used over the period of performance from July 2023 to July 2024 by the NIH's...